Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$637.59M
Operating Margin
-28.23%
TTM Avg
-27.16%
3Y Avg
-23.27%
5Y Avg
7.30%
Market Cap
$642.31M
Operating Margin
-12.47%
TTM Avg
-13.07%
3Y Avg
-26.14%
5Y Avg
-20.95%
Market Cap
$643.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$596.36M
Operating Margin
-975.91%
TTM Avg
-867.04%
3Y Avg
-586.91%
5Y Avg
-743.36%
Market Cap
$675.41M
Operating Margin
-187.24%
TTM Avg
-253932.81%
3Y Avg
-127981.70%
5Y Avg
-85456.42%
Market Cap
$579.88M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$573.38M
Operating Margin
-156.36%
TTM Avg
-104.91%
3Y Avg
-81.98%
5Y Avg
-81.61%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Climb Bio, Inc. (CLYM) | $632.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fulgent Genetics, Inc. (FLGT)vs › | $637.59M | -28.23% | -27.16% | -23.27% | 7.30% |
| AngioDynamics, Inc. (ANGO)vs › | $642.31M | -12.47% | -13.07% | -26.14% | -20.95% |
| Aura Biosciences, Inc. (AURA)vs › | $643.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | -975.91% | -867.04% | -586.91% | -743.36% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $675.41M | -187.24% | -253932.81% | -127981.70% | -85456.42% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Annexon, Inc. (ANNX)vs › | $688.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | -156.36% | -104.91% | -81.98% | -81.61% |
| CorMedix Inc. (CRMD)vs › | $569.56M | 46.95% | -1.63% | -11705.79% | -12269.85% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
